Медико-биологический
информационный портал
для специалистов
 
БИОМЕДИЦИНСКИЙ ЖУРНАЛ Medline.ru

СОДЕРЖАНИЕ ЖУРНАЛА:
Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


АРХИВ:

Фундаментальные исследования

Организация здравохраниения

История медицины и биологии



Последние публикации

Поиск публикаций

Articles

Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика


 РЕДАКЦИЯ:
Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии


 УЧРЕДИТЕЛИ:
Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"
(ФГБУН ИТ ФМБА России)

Институт теоретической и экспериментальной биофизики Российской академии наук.

ООО "ИЦ КОМКОН".




Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система
Искать: 


«
Vol. 14, Art. 67 (pp. 845-860)    |    2013       
»

Development experience of new technologies for russian blood service
Kiryanova G.U., Volkova S.D., Grishina G.V., Efimova T.A.

FGВU «Russian Research Institute of Hematology and Transfusiology
Federal medico-biological Agency», St. Peterburg



Brief summary

The article gives a substantiation of haemoсomponents leukodepletion and quarantine to increase the immunological and infectious safety of transfusions. Development stages of domestic devices for leukoreduction of blood, RBCs and plasma are presented. And here is offered a method for preparation leukodepleted quarantined erythrocytes. It is proved that leukofiltration has no negative impact on the morfo-functional properties of erythrocytes in the process of their cryopreservation, and that the erythrocyte medium is useful for transfusion.


Key words

leukodepletion, haemocomponents, domestic leukoreduction filters, safety, cryopreservation, quarantine.





(The article in PDF format. For preview need Adobe Acrobat Reader)



Open article in new window

Reference list

1. Aye M.T., Palmer D.S., Giulivi A., Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage // Transfusion. – 1995. – V.35, № 2. – P.117 – 124.


2. Heddle N.M. Pathophysiology of febrile nonhemolytic transfusion reactions // Curr. Opin. Hematol. – 1999. – V.6, №6. – P. 420 – 426.


3. King K.E., Shirey R.S., Thomas S.K. et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs // Transfusion –2004. – V44, №1 – P. 25-29.


4. Pruss A., Kalus U., Radtke H. et al. Universal leukodepletion of blood components results in a significant reduction of febrile nonhemolytic but not allergic transfusion reactions // Transfus. Apher. Sci. – 2004. – 30, №1. – P. 41-46.


5. Pygina N.V., Vilyaninov V.N., Romanenko S.M., Ignatovich G.P. Leikofiltraciya i kachestvo eritrocitosoderjashih gemokomponentov // Transfyziologiya. – 2009. – T.10, №1-2 – S. 53-54.


6. Shevchenko U.L., Shabalin V.N. i dr. Rykovodstvo po obshei i klinicheskoi transfyziologii. - SPb.: OOO «Izd. Foliant», 2003. - 608 c.


7. Nikitin I.K., Kozinec G.I. Krov, komponenti krovi: hranenie, frakcionirovanie, kachestvo i standarti // Gematol. i transfyziol. – 2002. – T.47, № 4. – S. 36 – 39.


8. Drakos S.G., Stringham J.C., Long J.W. et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions // Thorac. Cardiovasc. Surg. – 2007. – V.133, №6. – P. 1612-1619.


9. Williamson L.M., Stainsby D., Jones H. et al. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease // Transfusion – 2007. – V.47, №8 – P. 1455-1467.


10. Jibyrt E.B., Shestakov E.A., Kodnev A.T. i dr. Novoe v transfyziologii (na XIX regionalnom kongresse mejdynarodnogo obshestva perelivaniya krovi) // Transfyziologiya. – 2009. – T.10, №3-4 – S. 64-92.


11. Van Hust M., Bilgin Y.M., Watering L.M. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery // Transfusion Medicine. – 2005. – V.15, №3. – P. 209.


12. Blumberg N., Heal J.M., Gettings K.F. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions // Transfusion. – 2010. – V. 50, N 12. – P. 2738–2744.


13. Blumberg N., Lynn Fine, Gettings K.F. et al. Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions // Transfusion. – 2005. – V. 45, N 10. – P. 1632-1639.


14. Rysanov V.M. Virysnaya bezopasnost donorskoi plazmi // Vestnik slyjbi krovi Rossii – 2008. - №2 – S. 34-37.


15. Spichak I.I., Peshikova M.V., Kazachkova A.E., Jykovskaya E.V. Primenenie farmakoekonomicheskogo analiza dlya ocenki effektivnosti zatrat na povishenie biobezopasnosti gemotransfyzionnih sredstv s razlichnoi kontaminaciei leikocitami // Vestnik slyjbi krovi Rossii – 2010 . – №1. – S. 27-32.


16. Dumont L.J., Luka J., Vandenbrocke T. et al. The effect of leukocyte-reduction metod on the amont of human cytomegalovirus in blood products: a comparison of apheresis and filtration // Blood – 2001. – V.97, N11 – P. 3640-3647.


17. Qu L., Xu S., Rowe D., Triulzi D. Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells // Transfusion –2005. – V45, №4 – P. 591-595.


18. Visconti M.R., Pennington J., Garner S.F. et al. Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR // Blood – 2004. – V.103 – P. 1137-1139.


19. Wu Y., Zou S., Cable R. et al. Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction // Transfusion – 2010. – V.50, №4 – P. 776-786.


20. Cardo L.J., Salata J., Harman R. et al. Leukodepletion filters reduce Leishmania in blood products when used at collection or at the bedside //Transfusion –2006. – V46, №6 – P. 896-902.


21. Cardo L.J., Asher L. Electron micrographic stady of the removal of Trypanosoma cruzi from blood products by leukoreduction filters // Transfusion –2006. – V46, №7 – P.1067-1068.


22. Cardo L., Salata J., Wilder D. Removal of Plasmodium falciparum – infected red blood cells from whole blood by leukoreduction filters // Transfusion –2009. – V49, №.3 – P. 337-346.


23. Kim D.M., Brecher M.E., Bland L.A. et al. Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters // Transfusion – 1992. – V.32, №7. – R. 658-662


24. Yamaguchi H., Yamada M., Uruma T. et al. Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors // Transfusion – 2004. – V.44, №7 – P. 1072-1078.


25. Collaerts A.J., Gielis M.L., Sprengers E.D., Muylle L. The mechanism of white cell reduction by synthetic fiber cell filters // Transfusion. – 1993. – V. 33, N 2. – P. 134 – 138.


26. Brownlee L., Wardrop K.J., Sellon R.K., Meyers K.M. Use of a prestorage leukoreduction filter effectively removes leukocytes from canine whole blood while preserving red blood cell viability //J. Vet. Intern Med. – 2000 – V.14, N4 – P. 412-417.


27. Melnikova V.N., Selivanov E.A., Kiryanova G.U. i dr. Metod zagotovki leikofiltrovannih otmitih eritrocitov // Transfyziologiya. – 2010. – T.11, №3 – S. 4-11 .


28. Kylikov S.M., Garmaeva T.C., Zingerman B.V. i dr. Virysnaya bezopasnost gemotransfyzii i metodi ee ocenki // Gematol. i transfyziol. – 2008.– T. 53, № 4 – S.3-5.


29. Dashkova N.G., Rasnicin S.P., Ragimov A.A. i dr. Chastota viyavleniya markerov gemotransmissivnih infekcii y donorov // Vestnik slyjbi krovi Rossii – 2005. - №3 – S. 17-19.


30. Yaroslavceva N.G., Grymbkova L.O., Typoleva T.A i dr. Virysnaya bezopasnost gemotransfyzii: obespechivaut li ee prinyatie laboratornie metodi vibrakovki donorskoi krovi po gepatitam V i S // Gematol. i transfyziol. – 2006. – T. 51, №2 – S. 22-26.


31. Lazarenko M.I., Chechetkin A.V., Slashev V.V. i dr. Nekotorie voprosi bezopasnosti donorov i recipientov // Gematol. i transfyziol. – 2007. – T. 52, №3 – S. 52-54.


32. Chapman C.E., Stainsby D., Jones H. et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. // Transfusion. –2009. – V49, №3 – P. 440-452.


33. Muniz M., Sheldon S., Schuller R.M. et al. Patient-specific transfusion-related acute lung injury // Vox Sanquinis – 2008. – 94 – P.70-73.


34. Melnikova V.N., Selivanov E.A., Kiryanova G.U. i dr. Znachenie leikofiltracii pri kriokonservirovanii eritrocitov s celu ih karantinizacii // Vestnik slyjbi krovi Rossii. – 2010. – №4. – S. 3-7.


35. Bandarenko N., Cancelas J., Snyder E.L. Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system // Transfusion –2007. – V47, №4 – P. 680-686.


36. Vaskina E.A., Demyanova V.T., Zagoskina T.P. Chastota virysnih gepatitov y detei s onkogematologicheskimi zabolevaniyami // Vestnik gematologii – 2007– T.3, №2– S.11.


37. Garmaeva T.C., Kylikov S.M., Karyakin A.V. i dr. Monitorirovanie faktorov riska i indikatorov inficirovannosti virysami gepatitov V i S gematologicheskih bolnih // Gematol. i transfyziol. – 2006. – T. 51, № 1 – S. 23-27.


38. Fevraleva I.S., Glinshikova O.A., Makarik T.V., Sydarikov A.B. Myltipleksnaya diagnostika virysov gepatitov V, S i parvovirysa V19 y bolnih, polychaushih mnojestvennie gemotransfyzii // Gematol. i transfyziol. – 2008. – T. 53, № 4 – S. 54-56.



Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100